Results 141 to 150 of about 1,874,188 (207)

Home Administration of CVD 103-HgR: A Live Attenuated Oral Cholera Vaccine. [PDF]

Am J Trop Med Hyg, 2021
Duffin RP, Delbuono M, Chew L, Johnstone J, Niedan V, Schwarz P, Shabram P, Patel AA.   +7 more
europepmc   +1 more source

Oral cholera vaccine uptake, acceptance and confidence among residents of a high-risk township in Zambia: key insights for future vaccination programs. [PDF]

Int Health
Miti E, Mukosha M, Mwaba J, Mulavu M, Meyer JC, Mudenda S, Godman B, Mwila C, Hamachila A, Kalungia AC.   +9 more
europepmc   +1 more source

The opportunities & challenges in delivering oral cholera vaccines

Indian Journal of Medical Research, 2016
Deen, Jacqueline, Sack, David A.
openaire   +2 more sources

Real-world effectiveness of oral cholera vaccine amid fragility: A case-control study from Eastern Sudan, 2024. [PDF]

IJID Reg
Izzoddeen A, Abolgassim A, Yousif W, Elhussein EA, ElBushra E, Eltayeb D, Elhassan MMO, El-Bushra H.   +7 more
europepmc   +1 more source

Pre-emptive oral cholera vaccine (OCV) mass vaccination campaign in Cuamba District, Niassa Province, Mozambique: feasibility, vaccination coverage and delivery costs using CholTool. [PDF]

BMJ Open, 2022
Elias Chitio JJ, Baltazar CS, Langa JP, Baloi LD, Mboane RBJ, Manuel JA, Assane S, Omar A, Manso M, Capitine I, Van Rensburg C, Luiz N, Mogasale V, Marks F, Park SE, Beck NS.   +15 more
europepmc   +1 more source

Serological responses to killed oral cholera vaccine (OCV) when given 4 years after initial receipt of OCV in Cameroon: A randomized controlled trial. [PDF]

PLOS Glob Public Health
Ateudjieu J, Tchio-Nighie KH, Guenou E, Fokou C, Buh Nkum C, Beyala Bita'a L, Ateudjieu-Kenfack WD, Nanfak S, Debes AK, Sack DA.   +9 more
europepmc   +1 more source

Effect of HIV status and retinol on immunogenicity to oral cholera vaccine in adult population living in an endemic area of Lukanga Swamps, Zambia. [PDF]

PLoS One, 2021
Luchen CC, Mwaba J, Ng'ombe H, Alabi PIO, Simuyandi M, Chilyabanyama ON, Hatyoka LM, Mubanga C, Bosomprah S, Chilengi R, Chisenga CC.   +10 more
europepmc   +1 more source

Dual-Use Vaccine for Diarrhoeal Diseases: Cross-Protective Immunogenicity of a Cold-Chain-Free, Live-Attenuated, Oral Cholera Vaccine against Enterotoxigenic Escherichia coli (ETEC) Challenge in BALB/c Mice. [PDF]

Vaccines (Basel), 2022
Hui Xian T, Parasuraman S, Ravichandran M, Prabhakaran G.   +3 more
europepmc   +1 more source

Descriptive analysis of adverse events following immunization with oral cholera vaccine in Lebanon. [PDF]

Front Public Health
Zeitoun A, Ibrahim A, Reda El Sayed S, Hobeika E, Karam R.   +4 more
europepmc   +1 more source

Effectiveness of a killed whole-cell oral cholera vaccine in Bangladesh: further follow-up of a cluster-randomised trial. [PDF]

Lancet Infect Dis, 2021
Ali M, Qadri F, Kim DR, Islam MT, Im J, Ahmmed F, Khan AI, Zaman K, Marks F, Kim JH, Clemens JD.   +10 more
europepmc   +1 more source